Product image of Glucagen Hypokit (Glucagon) supplied by GNH India

Glucagen Hypokit

Active Ingredient:
Glucagon
Origin:
EU

Glucagen Hypokit (Glucagon)

Glucagen Hypokit is a prescription medication that contains the peptide hormone glucagon as its active ingredient. It is supplied in a kit format for emergency use, though specific strength and dosage form are not disclosed. The product is marketed in the European Union and is administered by intramuscular, intravenous, or subcutaneous injection to promptly and effectively raise blood glucose levels in patients experiencing severe hypoglycemia.

Manufacturer / TM Owner

Novo Nordisk A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glucagen Hypokit is indicated for the treatment of severe hypoglycemia when rapid restoration of blood glucose is required.

  • Emergency treatment of insulin‑induced hypoglycemia in diabetic patients.
  • Management of hypoglycemia unawareness where oral carbohydrate intake is insufficient.
  • Use in a clinical setting when intravenous dextrose is unavailable or delayed.
  • Administration by trained personnel during a hypoglycemic crisis in outpatient or home environments.

Side Effects

The safety profile of glucagon includes both frequently observed and less common adverse reactions.

Common

  • Nausea or vomiting.
  • Headache.
  • Flushing or warmth.
  • Injection‑site pain or bruising.
  • Transient hyperglycemia.
  • Dizziness.

Serious

  • Allergic reactions including rash or urticaria.
  • Anaphylaxis.
  • Cardiovascular events such as tachycardia or arrhythmia.
  • Severe hyperglycemia leading to osmotic diuresis.
  • Hypotension.
  • Pulmonary edema in susceptible individuals.

Precautions & Warnings

Before using Glucagen Hypokit, healthcare providers should consider several precautionary measures to ensure safe administration.

  • Verify diagnosis of severe hypoglycemia before injection.
  • Assess for known hypersensitivity to glucagon or any kit components.
  • Use caution in patients with pheochromocytoma or adrenal insufficiency.
  • Monitor cardiac status in patients with recent myocardial infarction.
  • Avoid use in patients with severe renal impairment without specialist advice.
  • Ensure proper storage conditions to maintain peptide stability.

Avoid Interactions

Glucagon may interact with other medications, influencing its effectiveness or safety.

Avoid

  • Concurrent use of beta‑blockers may blunt the hyperglycemic response.
  • Combination with insulin secretagogues can increase risk of recurrent hypoglycemia.

Use with caution

  • Concomitant use of catecholamines may augment cardiovascular effects.
  • Co‑administration with oral hypoglycemic agents requires close glucose monitoring.
  • Interaction with corticosteroids may affect glucose metabolism.
  • Use alongside other vasoactive agents should be supervised by a clinician.

Frequently Asked Questions

Glucagen Hypokit is a prescription kit that contains glucagon, a peptide hormone that stimulates liver glycogenolysis and gluconeogenesis, rapidly increasing blood glucose levels during severe hypoglycemia.

It should be used when a patient experiences severe hypoglycemia that requires immediate glucose elevation, especially when oral carbohydrate intake is not possible or intravenous dextrose is delayed.

The kit is designed for intramuscular, intravenous, or subcutaneous injection by trained personnel, depending on the clinical situation and available access.

Glucagon in this kit can be given intramuscularly (IM), intravenously (IV), or subcutaneously (SC) to achieve rapid systemic absorption.

Common adverse effects include nausea, vomiting, headache, flushing, injection‑site pain, transient hyperglycemia, and dizziness.

Serious reactions may include allergic responses such as rash or anaphylaxis, cardiovascular events like tachycardia or arrhythmia, severe hyperglycemia with osmotic diuresis, hypotension, and, rarely, pulmonary edema.

Patients with known hypersensitivity to glucagon or kit components, and those with pheochromocytoma or adrenal insufficiency should avoid use unless specifically directed by a specialist.

Confirm severe hypoglycemia, review allergy history, assess cardiac and renal status, ensure proper storage, and have trained personnel perform the injection.

Yes. Beta‑blockers may reduce its glucose‑raising effect, and insulin secretagogues can increase the risk of recurrent hypoglycemia. Catecholamines, oral hypoglycemics, and corticosteroids may require careful monitoring.

The kit should be kept at the temperature recommended by the manufacturer, protected from light and moisture, and not frozen, to preserve glucagon stability.

Glucagen Hypokit is classified as a prescription‑only medication (Rx) in the European Union.

If signs of an allergic reaction such as rash, swelling, or difficulty breathing appear, discontinue use and seek immediate medical attention, following standard anaphylaxis protocols.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glucagon

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT